Sarcomatrix Therapeutics Appoints Dr. Jeff Myers as Chief Medical Officer
Experienced biopharmaceutical executive and former cardiothoracic surgeon joins company as lead candidate S-969 advances toward IND submission RENO, NV, UNITED STATES, July 17, 2026 /EINPresswire.com/ -- Sarcomatrix Therapeutics, a …